The nucleosome is a major autoantigen known to activate PMN in systemic lupus erythematosus (SLE). TLR9 recognizes bacterial and even mammalian DNA under certain circumstances. Nevertheless, the role of TLR9 in SLE development is still unclear. Since nucleosomes are composed of DNA, we investigated whether TLR9 is required for nucleosome-induced PMN activation. Isolated neutrophils were cultured with nucleosomes, plasma from lupus patients and other stimuli in the presence/absence of various inhibitors. Cells were analyzed by flow cytometry, ELISA and confocal microscopy. We found that nucleosomes circulating in lupus plasma induce the secretion of pro-inflammatory cytokines by PMN. Nucleosomes activate human PMN independently of unmethylated CpG sequences in nucleosomal DNA, leading to IL-8/IL-6/TNF secretion and CD11b up-regulation. Nucleosomes accumulate in the cytoplasm of PMN upon endocytosis, induce TLR9 up-regulation and act synergistically with TLR9 ligands. Nucleosomeinduced activation was not inhibited by polymyxin B (PB), chloroquine (CQ), ammonium chloride (AC) or a TLR9 antagonist. Moreover, both PMN isolated from WT and TLR9-KO mice were activated by nucleosomes, as detected by MIP-2 secretion and CD11b upregulation. Activation occurred therefore independently of endotoxins, endosomal acidification, TLR9 and CpG motifs. TLR9 may thus be differently required in the triggering of nucleosome-induced innate immunity and anti-nucleosome B-cell autoimmunity.Key words: Cell activation . Inflammation . Neutrophils . Nucleosomes . Systemic lupus erythematosus Supporting Information available online
IntroductionSystemic lupus erythematosus (SLE) is a rheumatic autoimmune disease of unknown etiology. It is a systemic inflammatory disease characterized by the production of numerous autoantibodies (autoAbs). Upon binding to their target autoantigens (autoAgs), the resulting immune complexes deposit into tissues causing inflammation and damages.The nucleosome is a major lupus autoAg composed of dsDNA and histones. Circulating nucleosomes are present in the blood of SLE patients [1] and increased concentrations are associated with the development of nervous and renal manifestations [2]. Nucleosome-restricted autoAb [3] and nucleosome-specific autoreactive T-helper lymphocytes [4] are also observed in SLE patients and the former strongly correlate with disease activity scores [5]. It is therefore believed that circulating nucleosomes trigger the production of anti-nucleosome, anti-histone and antidsDNA autoAb (a disease marker in SLE), although the exact mechanisms leading to anti-nucleosome autoimmunity are not completely elucidated. PMN are the first cells recruited at inflammation sites. Upon inappropriate activation, PMN-derived reactive species may induce tissue damages and may alter self-antigens. PMN are activated in SLE patients [6,7], especially during active disease, and secrete IL-8 (CXCL8), the concentration of which correlates to disease activity [8]. Importantly, PMN have been suggested to link the i...